Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managi...
This American Gastroenterological Association (AGA) living guideline is intended to support practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC).
A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessme...
Adler, Jeremy;
Ananthakrishnan, Ashwin N;
Chachu, Karen A;
Cohen, Benjamin L;
Nguyen, Nghia H;
Siddique, Shazia M;
Singh, Siddharth;
Sultan, Shahnaz;
Velayos, Fernando S;
Weiss, Jennifer M.
Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD.
A multidisciplinary panel of content ...
Since the early 2000s, there has been a rapid
decline in colorectal cancer (CRC) mortality, due in large part
to screening and removal of precancerous polyps. Despite
these improvements, CRC remains the second leading cause
of cancer deaths in the United States, with approximately
53,000 deaths projected...
Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/
threshold level of specific pancreatic digestive enzymes to the
intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies. EPI is freque...
Singh, Siddharth;
Ananthakrishnan, Ashwin N;
Nguyen, Nghia H;
Cohen, Benjamin L;
Velayos, Fernando S;
Weiss, Jennifer M;
Sultan, Shahnaz;
Siddique, Shazia M;
Adler, Jeremy;
Chachu, Karen A.
Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the managemen...
Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...
Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...
The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis due to chronic Helicobacter pylori infection-the most common...
